NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Just posting for others, as I know you ignore me,

Warrants, and options, are evaluated by various mathematical models. These take into account the price, strike, beta, expiration and cost of risk free capital.

The most well known of these is Black-Schoals.

The value of these outstanding warrants is on the books as "Derivative Liability" (or warrant liability).

At the end of Q2 it was a modest $60M. At the end of Q3 it will be about $250M. As of today, it is around $700M. [all approx, as the company creates some input assumptions into the models].

These are the numbers that NWBO refers to as being a significant change from prior Qs.

I think they are material, but who knows here on pluto. Maybe we will actually see some required SEC disclosures some day.

[BTW, from a quick check, the earliest OTC is likely to act and "pink" them would be the first week of Jan. So plenty of time to slow play this]